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Figure 1. Distribution of LAVi in Healthy Subjects (N [ 285)
The short black arrow points to the mean indexed left atrial volume (LAVi) of
30.3 ml/m2, which is greater than the current published reference value of 22
ml/m2 for normal (long black arrow).
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530A limitation of this study is that coronary CTA was performed
within clinical workup, which could implicate referral bias. Possibly,
clinical information known to the reader might have inﬂuenced
coronary CTA assessment as well. The nonsigniﬁcant difference in
event rate between men and women with normal coronary CTA
might be due to differences in risk factors or referral patterns, which
this study did not have the power to detect.
In conclusion, obstructive CAD signiﬁcantly predicted events in
both men and women. Despite the small numbers and hypothesis-
generating nature of our study, these ﬁndings further validate the
role of coronary CTA to effectively risk stratify women and men.
Mathijs O. Versteylen, MD, PhD,* Ivo A. Joosen, MD, PhD,
Bas L. Kietselaer, MD, PhD, Joachim E. Wildberger, MD, PhD,
Harry J. Crijns, MD, PhD, Leonard Hofstra, MD, PhD
*Department of Cardiology, Cardiovascular Research Institute Maas-
tricht, Maastricht University Medical Center, P Debyelaan 25,
Maastricht, the Netherlands. E-mail: mathijs.versteylen@gmail.com
http://dx.doi.org/10.1016/j.jcmg.2013.08.018
Please note: Dr. Wildberger has received institutional grants from Bayer Healthcare,
Siemens Healthcare, GE Healthcare, Philips Healthcare, Agfa Healthcare, and Bracco.
All other authors have reported that they have no relationships relevant to the contents
of this paper to disclose.
R E F E R E N C E S
1. Min JK, Dunning A, Lin FY, et al., for the CONFIRM Investigators.
Age- and sex-related differences in all-cause mortality risk based on
coronary computed tomography angiography ﬁndings results from the
International Multicenter CONFIRM (Coronary CT Angiography
Evaluation for Clinical Outcomes: An International Multicenter Registry)
of 23,854 patients without known coronary artery disease. J Am Coll
Cardiol 2011;58:849–60.
2. Lansky AJ, Ng VG, Maehara A, et al. Gender and the extent of coronary
atherosclerosis, plaque composition, and clinical outcomes in acute coro-
nary syndromes. J Am Coll Cardiol Img 2012;5 Suppl 3:S62–72.
3. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable
plaque. J Am Coll Cardiol 2006;47 Suppl 8:C13–8.
4. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without
rupture into a lipid core: a frequent cause of coronary thrombosis in
sudden coronary death. Circulation 1996;93:1354–63.
Left Atrial Volumes
Should We Reset the Reference Standard?
Left atrial (LA) volume has been shown to be a prognostic indicator
of cardiovascular (CV) events and a marker of diastolic dysfunction
(1,2). Normative values for indexed LA volume (LAVi) have been
established to be 22  6 ml/m2 (3). Yet, these values are on the basis
of small sample size studies, from a period with different imaging
technology and using inconsistent measurement techniques.
We aimed to re-examine the normal reference standards for
LAVi in a contemporary healthy population. We searched our
institutional database for a 1-year period to identify healthy subjects
with normal echocardiograms. Medical records were comprehen-
sively reviewed to select healthy patients (no CV risk factors,
pulmonary or renal disease). LA volume was calculated by thebiplane area–length method (3). Diastolic parameters were assessed.
Furthermore, a healthy validation subset of 20 subjects was exam-
ined prospectively.
From June 2009 to June 2010, 285 healthy subjects were
identiﬁed and LA volumes measured. The mean LAVi was 30.3 
6 ml/m2 (mean age 38.3  14.8 years, 61.4% women) with no
difference observed between men and women (30.3  7.0 ml/m2
vs. 30.5  6.0 ml/m2, p ¼ 0.81) and no age differences in absolute
or indexed LA volumes in the entire healthy cohort or by sex.
Mean diastolic parameters were normal. Thirty percent
of subjects had a LAVi $34 ml/m2da cutoff used to iden-
tify those with abnormal diastolic function (1). E/A, average
E0, and E/E0 were not signiﬁcantly different between this group
and those with a LAVi <34 ml/m2. The prospective cohort of
20 healthy subjects, matched to age (38.3  7.0 years), sex
(60% women), and body surface area (1.8  0.2 m2) had similar
mean LAVi to the retrospective cohort (31.7  6.0 ml/m2 vs. 30.3
 7.0 ml/m2; prospective vs. retrospective p ¼ 0.35).
Reassessment of LAVi in a contemporary healthy cohort suggests
that normative reference ranges of LAVi should be higher than
previously reported. In the present study, the mean LAVi in healthy
subjects was 30.3  6.5 ml/m2, 38% higher compared with current
reference values for mean normal LAVi (22  6 ml/m2) (3) (Fig. 1).
Various factors may account for the discrepancy be-
tween previously reported values and our results. Current
reference values are on the basis of relatively small sample size
studies and obtained from a period with different imaging tech-
nology. With improved spatial resolution in current imaging
systems, measurement of LA boundaries may be more accurate.
The conﬂuence of the pulmonary veins may also be better
Figure 1. Frequency of Unexpected 99mTc-DPD Myocardial Uptake
Prevalence of myocardial tracer uptake according to age (A) and age and sex
(B) among the 12,400 patients who underwent 99mTc-3,3-diphosphono-1,2-
propanodicarboxylic acid (99mTc-DPD) scintigraphy.
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531visualized, thus avoiding inadvertent extension of the LA length
measurement into the pulmonary veindan error that results in
smaller LA volumes. In addition, there has been a lack of con-
sistency in methods used to calculate LAVi. Prior studies have
reported LA volumes using biplane area-length, biplane Simpson’s,
and prolate ellipsoid methods (1,2,4).
LAVi is considered a marker of diastolic dysfunction (1), with a
current cutoff value of 34 ml/m2 used to indicate elevated left
ventricular ﬁlling pressures in the setting of an E/E0 between 9 and
14. In our study, however, 30% of healthy subjects had a LAVi
$34 ml/m2 in the presence of normal echocardiographic indexes of
left ventricular ﬁlling pressures.
This study is a retrospective analysis, and measurements were not
performed blinded to the clinical data and thus are subject to se-
lection and information bias.
In conclusion, reassessment of LAVi in a contemporary healthy
cohort suggests higher normative reference ranges than previously
published. Establishing normative values for LA volumes are
important for clinical decision making, given the signiﬁcant asso-
ciation that has been reported between increased LA volume and
prognosis in a wide range of CV diseases.
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Identiﬁcation of TTR-Related
Subclinical Amyloidosis
With 99mTc-DPD Scintigraphy
We have previously documented that 99mTc-3,3-diphosphono-1,2-
propanodicarboxylic acid (99mTc-DPD) has a high afﬁnity for
transthyretin (TTR)-inﬁltrated myocardium, allowing a differential
diagnosis with light-chain cardiac amyloidosis (1) and other non-
amyloidotic cardiomyopathies with a hypertrophic phenotype (2).
Notably, 99mTc-DPD allows an early diagnosis of TTR-related
cardiac amyloidosis, even before the appearance of overt echocar-
diographic or electrocardiographic abnormalities (3). However, the
potential role of this technique in the pre-clinical populationscreening has not been explored yet. We therefore evaluated prev-
alence and implications of incidental myocardial uptake among
patients undergoing 99mTc-DPD scintigraphy for oncologic/rheu-
matologic reasons.
We retrospectively analyzed all 99mTc-DPD scintigraphies per-
formed at our institution between 2008 and May 2013. Scintigraphy
protocol and image analysis have been previously described (1).
During the study period, 12,521 patients underwent scintigraphy,
including 121 with suspected cardiac amyloidosis: these patients were
excluded. The study population therefore consisted of 12,400 pa-
tients with oncologic (95%) or rheumatologic (5%) indications to
scintigraphy (37% men; mean age 74 years; range 65 to 82 years).
Myocardial tracer uptake was present in 45 subjects (0.36%; 62%
men; median age 81 years; range 77 to 84 years), and an associated
localized area of bone metastatic activity was present in a single case.
Speciﬁcally, myocardial uptake was strong in 40 cases (89%) and
moderate in 5 (11%). The prevalence of incidental uptake increased
progressively with age (Fig. 1).
Thirty-two of 45 patients showing myocardial uptake were
contacted and offered a comprehensive cardiological evaluation
including ECG, echocardiography, and endomyocardial biopsy in
selected cases. Fourteen patients agreed to be evaluated (11 men;
